Industry

German drug maker Boehringer Ingelheim said it has won approval from the Indian drug regulator (CDSCO) to market its top-selling type-2 diabetes medication, Jardiance (empagliflozin),...

New Delhi: Drug major Sun Pharmaceutical Industries is recalling over 1.10 lakh bottles of a generic medication used to treat erectile dysfunction...

Drug firm Zydus Cadila on Saturday said it has received approval from the US health regulator to market Decitabine injection, used to treat certain types of...

New Delhi: Rejecting the drug major Synokem Pharma's proposal for oral anti-diabetic medication Imeglimin 500mg and 1000mg Tab, the Subject Expert Committee (SEC)...

Mumbai: Generic pharmaceutical company BDR Pharma launched generic drug Biapenem (BIAPEN) to treat patients with intra-abdominal infections, lower respiratory infections, or complicated urinary tract infections.

The US drug major Eli Lilly is fighting a patent infringement litigation against several Indian pharma companies for the intellectual property rights...

Natco Pharma Limited has launched a novel fixed-dose combination (FDC) of trifluridine and tipiracil for the first-time in India under the brand...

Mumbai: Alembic Pharmaceuticals Limited announced that its joint venture Aleor Dermaceuticals Limited has received final approval from the US Food & Drug Administration (USFDA)...

Cipla announced the launch of Spirofy, India’s first pneumotach-based portable, wireless Spirometer, on World COPD Day. The company...

New Delhi: Pharmaceutical major Cadila Healthcare has got a green signal from the Subject Expert Committee (SEC) functional under the Central Drugs Standard...

Sun Pharma recently said that it is gearing up to introduce Merck Sharpe Dohme (MSD) and Ridgeback’s Molnupiravir under the brand name...

New Delhi: Zydus Cadila’s C-19 vaccine, ZyCov-D, which has been cleared by India’s drug regulator for those aged 12 years and above, will...

Zydus Cadila said today that its US subsidiary, Zydus Pharmaceuticals (USA) Inc., has obtained provisional permission from the US Food and Drug Administration (USFDA) to comercialise Eluxadoline Tablets in 75 mg and 100 mg dosages (US RLD: VIBERZI Tablets). Irritable bowel syndrome with diarrhoea or IBS-D, is treated with Eluxadoline Tablets in adults.

MUMBAI: Sun Pharma said on Thursday it is gearing up to introduce antiviral Covid-19 drug, molnupiravir under the brand Molxvir at "an economical price'' in India....

Ahmedabad, India: Global pharmaceutical company Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market its glycopyrrolate injection,...

DMA urges Govt to allow Pharma industry to hike Drugs Prices The Indian Drug Manufacturers’ Association (IDMA) has...

Fair trade regulator, the Competition Commission of India (CCI) will identify measures to enhance competition in the country's pharmaceutical sector to ensure the affordability of...

Pharma industry seeks Govt to remove ban on Methylcobalamin (Vitamin B12) The pharmaceutical industry has sought the intervention...

The USFDA has approved amphetamine (Dyanavel XR, Tris Pharma) extended-release once daily tablet, for the treatment of individuals 6 years of age...

Leading drug makers Sun Pharma and Lupin are recalling different products in the US, the world's largest market for medicines, for different reasons.

New Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has granted permission to drug-maker Torrent Pharmaceuticals...

Global pharma major Lupin Limited announced the launch of the authorized generic version of Antara (Fenofibrate) capsules, 30 mg and 90 mg,...

New Delhi: Gland Pharma, which operates primarily under a business-to-business model, is looking at complex injectables segment, contract development, and manufacturing of biosimilars...

NEW DELHI: Biotechnology firm Novavax Inc said it has completed the rolling submission for the emergency use listing (EUL) of its Covid-19 vaccine candidate...